NewsMarkets

Science

CryoEM reveals HSV-2 fusion mechanism for potential treatment targets

Researchers identify a conserved molecular switch in the HSV-2 gH/gL protein complex that governs viral entry into cells.

1 publisher · 1 article · first seen 27 Oct 2026 · updated 11d ago

Headline and summary written by an AI model from the linked article; not reviewed by a person. How this was made

This story has stopped developing; this page is its permanent record. More from that day

The story so far

1 publisher has covered this in 1 article since 27 Oct 2026. Nature Communications published first, on 27 October at 00:00 UTC.

No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.

Sources

Every article we clustered into this story. Headlines link to the publisher.

  1. Distinct conformational states of HSV-2 gH/gL captured by cryoEM reveal structural principles governing fusion activation Nature Communications ·
Embed this story

Paste this into any web page to show the live odds, with a link back here.